- EXPLORER-HCM - new possibilities in the treatment of outflow tract obstruction in hypertrophic cardiomyopathy2021 | First Faculty of Medicine
- Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation2018 | Publication without faculty affiliation
- Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study Design2024 | Publication without faculty affiliation
- Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)2019 | Publication without faculty affiliation
- Genetic testing in patients with hypertrophic cardiomyopathy +12019 | Publication without faculty affiliation
- Patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation have favorable long-term outcome irrespective of their genetic background2020 | Second Faculty of Medicine
- Head-Up Tilt Test in Risk Stratification of Patients with Hypertrophic Cardiomyopathy2019 | Publication without faculty affiliation
- Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy2005 | Publication without faculty affiliation
- Treatment of hypertrophic cardiomyopathy2005 | Central Library of Charles University
- Fabry disease: Percutaneous transluminal septal myocardial ablation markedly improved symptomatic left ventricular hypertrophy and outflow tract obstruction in a classically affected male2005 | First Faculty of Medicine
- The diagnosis and management of hypertrophic cardiomyopathy +12011 | Publication without faculty affiliation
- Narrative review on Morbus Fabry: diagnosis and management of cardiac manifestations2021 | First Faculty of Medicine
- Several myths about hyperthrophic cardiopathy2007 | Publication without faculty affiliation
- Sequence analysis of myozenin 2 in 438 European patients with familial hypertrophic cardiomyopathy2008 | Publication without faculty affiliation
- Lessons We Learned About Sudden Death in Hypertrophic Cardiomyopathy2022 | Publication without faculty affiliation
- Hypertrophic Cardiomyopathy Is at Increased Risk of Thromboembolic Events: Deficiencies of CHA(2)DS(2)-VASC Score and How to Predict2019 | Publication without faculty affiliation
- Rediscovering therapies for hypertrophic cardiomyopathy2023 | Publication without faculty affiliation
- Uncomplicated Pregnancy in a Patient Treated With Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy2017 | Publication without faculty affiliation
- Pathology of hypertrophic cardiomyopathy2008 | First Faculty of Medicine
- Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?2023 | Publication without faculty affiliation
- Clinical and morphological variables influencing the results of genetic testing of patients with hypertrophic cardiomyopathy2014 | Publication without faculty affiliation
- Genetic variation screening of TNNT2 Gene in a cohort of patients with hypertrophic and dilated cardiomyopathy2012 | First Faculty of Medicine
- Pathology of hypertrophic cardiomyopathy +12008 | Faculty of Medicine in Hradec Králové
- Patterns of Electrocardiographic Abnormalities in Children with Hypertrophic Cardiomyopathy2024 | Publication without faculty affiliation
- Tumour necrosis factor-alpha soluble receptors type I are related to symptoms and left ventricular function in hypertrophic cardiomyopathy2001 | Third Faculty of Medicine
- The utility of the Mayo Score for predicting the yield of genetic testing in patients with hypertrophic cardiomyopathy2019 | Second Faculty of Medicine
- Low procedure-related mortality achieved with alcohol septal ablation in European patients2016 | Publication without faculty affiliation
